文献速递术前评估与围术期医学神经外科与老年麻醉

术前生物流体标志物预测老年术后神经认知障碍的系统综述

Preoperative Biofluid Biomarkers for Predicting Postoperative Neurocognitive Disorders in Older Adults: A Systematic Review.
PubMed 文献 · Anesth Analg · 2024-11-21

该系统综述纳入15项研究共2103例≥60岁手术患者,汇总术前生物流体标志物与术后7天以上认知下降的关联。采用二分类认知结局的9项研究中,术后认知功能障碍发生率在<3个月为23.4%(95%CI 6.6-46.2),3至<12个月为11.4%(95%CI 8.1-15.0),≥12个月为6.9%(95%CI 1.9-14.5)。淀粉样蛋白标志物证据最有希望,5项研究中4项显示术前水平较低与风险增加相关。

要点

  • 术前血或脑脊液淀粉样蛋白标志物水平较低可能与术后认知功能障碍风险增加相关。
  • 术后认知功能障碍汇总发生率随时间下降:<3个月23.4%,3至<12个月11.4%,≥12个月6.9%。
  • 证据受认知评估工具和时间框架异质性限制,需标准化结局指标。

核心结论

  • 术前生物流体淀粉样蛋白标志物可能有助于预测术后认知功能障碍,但当前证据仍有限。
  • p-Tau181和神经丝轻链也是潜在标志物,但样本量小、研究异质性和结果矛盾限制结论。

研究设计与样本

  • 系统综述,检索6个数据库和3个试验注册库至2024年1月17日。
  • 纳入15项研究共2103例≥60岁手术患者,评估术前生物标志物与术后7天以上认知下降的关联。
  • 排除临床前研究、颅内手术和年龄<60岁的研究。

主要发现

  • 9项研究使用二分类认知结局,术后认知功能障碍发生率<3个月为23.4%(95%CI 6.6-46.2)。
  • 3至<12个月发生率为11.4%(95%CI 8.1-15.0),≥12个月为6.9%(95%CI 1.9-14.5)。
  • 15项研究中9项评估血液标志物,4项评估脑脊液标志物,2项同时评估两者。
  • 标志物反映神经元损伤(9项)、炎症(5项)、淀粉样蛋白(5项)和Tau(1项)。
  • 淀粉样蛋白标志物证据最有希望,5项研究中4项显示术前水平较低与术后认知功能障碍风险增加相关。

关键数值与推荐

  • 纳入研究质量中等至高等。
  • 认知结局指标和评估时间框架异质性明显,限制定量合成。

临床怎么用

  • 术前可考虑检测血或脑脊液淀粉样蛋白标志物以辅助老年患者术后认知功能障碍风险分层。
  • 解释标志物结果时需结合当前证据的局限性,不宜单独作为决策依据。

局限性

  • 认知结局指标和评估时间框架异质性大,无法进行定量合成。
  • 部分标志物研究样本量小、结果矛盾。
  • 需标准化认知结局指标和统一评估时间框架以明确预后价值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Preoperative biofluid biomarkers reflecting pathophysiological, neuronal injury, and inflammation as well as those for Alzheimer's disease (AD) may be valuable tools for the risk stratification of perioperative neurocognitive disorders (PNDs) in older adults. We summarized current evidence relating these preoperative biomarkers to PND beyond 7 days, in older surgical participants aged ≥60 years. Studies that evaluated the association of preoperative biomarkers with cognitive decline as an outcome, beyond 7 days, were identified through searches of 6 databases and 3 trial registries to 17 January 2024. Preclinical studies, intracranial surgical, or studies with participants aged <60 years were excluded. Studies varied widely in the assessment of PND, so a wide range of cognitive outcomes was accepted, including those using the term postoperative cognitive dysfunction (POCD) to define cognitive decline. The pooled incidence of POCD utilizing a binary cognitive outcome was summarized. Fifteen studies involving 2103 participants were included. Marked heterogeneity was evident in the cognitive outcome metrics, assessment timeframes, limiting a quantitative synthesis. Of the 9 studies using binarized cognitive outcomes, the incidence of POCD was 23.4% (95% confidence interval [CI], 6.6-46.2) at <3 months, 11.4% (95% CI, 8.1-15.0) at 3 to <12 months, and 6.9% (95% CI, 1.9-14.5) at ≥12 months postoperatively. Of the 15 studies, 9 described blood-based biomarkers, 4 described cerebrospinal fluid (CSF) biomarkers, and 2 measured both blood and CSF markers. The biomarkers evaluated reflected the pathogenic indicators neuronal injury (9 studies), inflammation (5 studies) and of amyloid (5 studies), and Tau (1 study). The studies included were of medium to high quality. Evidence was the most promising for amyloid biomarkers, with 4 of 5 included studies demonstrating associations of lower preoperative biofluid amyloid biomarker levels with increased risk of POCD. In conclusion, preoperative biofluid amyloid biomarkers may hold potential utility for the prediction of POCD, although current evidence remains limited. Other potential preoperative biomarkers for POCD included p-Tau181 and Neurofilament Light, however small sample sizes, study heterogeneity, and conflicting results limited conclusions drawn. Standardized cognitive outcome metrics and common assessment timeframes are additionally required in future studies to ascertain the prognostic utility of these biomarkers for POCD.

来源:Anesth Analg,查看原文。版权归原作者所有。

引用

  1. Sim MA, Wilding H, Atkins KJ, et al. Preoperative Biofluid Biomarkers for Predicting Postoperative Neurocognitive Disorders in Older Adults: A Systematic Review. Anesth Analg. 2024. PMID: 39652372. doi:10.1213/ANE.0000000000007316

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。